Acute Myeloid Leukemia: Gemtuzumab Ozogamicin Study for Children

We are testing a new treatment combining gemtuzumab ozogamicin with standard chemotherapy for children with acute myeloid leukemia. The study aims to find the best dose and compare its effectiveness with current therapies.

Confirmation phase (III)No PlaceboStandard MedicinesInjectionOncologyPediatrics

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Cytarabine
Mitoxantrone Sandoz
Mitoxantrone Sandoz is a chemotherapy medicine used to treat certain cancers and some types of multiple sclerosis.
Mylotarg
Mylotarg is a cancer medicine used to treat acute myeloid leukemia, a type of blood cancer.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Busulfan
Busulfan is a substance used to destroy bone marrow cells before a bone marrow transplant and to treat certain blood cancers.
Cyclophosphamide
Cyclophosphamide is a cancer-fighting and immune-suppressing substance used to treat various cancers and some severe autoimmune conditions.
Cytarabine
Cytarabine is a chemotherapy substance used to treat certain blood cancers, especially acute leukemias.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Alexan
Ara-Cell
Aracytin

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Universitaire D'Angers
Service d' Hématologie-Oncologie Pédiatrique
Angers, France
Centre Hospitalier Universitaire De Toulouse
Service de Pédiatrie hématologie Oncologie
Blagnac, France
University Of Bordeaux
Service de Pédiatrie médicale
Bordeaux, France
Sponsor: The University Of Birmingham
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.